Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-30

Clinical Trial Update: Study to Investigate the Efficacy of Symbicort® SMART. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Symbicort SMART for asthma has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Symbicort SMART (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2012-11-30